Literature DB >> 19066769

In vitro drug sensitivity testing in Plasmodium vivax.

Walther H Wernsdorfer1, Oumaporn Tasanor, Gunther Wernsdorfer.   

Abstract

The possibility of short-term in vitro cultivation, i.e. growth of asexual erythrocytic stages up to the stage of mature schizonts, permits in principle the development of drug sensitivity tests also for Plasmodium vivax. In the absence of a sequestration of erythrocytes carrying the advanced stages of schizogony, asexual parasites of all stages may be seen in the peripheral blood of patients infected with P. vivax. This precludes schizont maturation tests since schizont development will be unduly influenced by the number of advanced trophozoites. A test system reflecting the age composition of the parasite population and its progression without and under the influence of inhibitors was found to yield precise results also in the higher IC ranges. The population-based test procedure would also permit the identification of any stage-specific impact of antimalarial agents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19066769     DOI: 10.1007/s00508-008-1030-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  16 in total

1.  Plasmodium vivax resistance to chloroquine?

Authors:  K H Rieckmann; D R Davis; D C Hutton
Journal:  Lancet       Date:  1989-11-18       Impact factor: 79.321

2.  A mixed infection of vivax and falciparum malaria apparently resistant to 4-aminoquinoline: a case report.

Authors:  G J Schuurkamp; P E Spicer; R K Kereu; P K Bulungol
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Sep-Oct       Impact factor: 2.184

3.  Effects of chloroquine, quinine, and cycloguanil upon the maturation of asexual erythrocytic forms of two strains of Plasmodium falciparum in vitro.

Authors:  K H Rieckmann; J V McNamara; H Frischer; T A Stockert; P E Carson; R D Powell
Journal:  Am J Trop Med Hyg       Date:  1968-09       Impact factor: 2.345

4.  Development of in vitro microtest for the assessment of Plasmodium vivax sensitivity to chloroquine.

Authors:  C R Brockelman; P Tan-Ariya; D Bunnag
Journal:  Southeast Asian J Trop Med Public Health       Date:  1989-03       Impact factor: 0.267

5.  Comparative study on the in vitro activity of lumefantrine and desbutyl-benflumetol in fresh isolates of Plasmodium vivax from Thailand.

Authors:  Daniela K Pirker-Krassnig; Gunther Wernsdorfer; Jeeraphat Sirichaisinthop; Chaiporn Rojanawatsirivet; Herwig Kollaritsch; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2004       Impact factor: 1.704

6.  Susceptibility to chloroquine, mefloquine and artemisinin of Plasmodium vivax in northwestern Thailand.

Authors:  Birgit Woitsch; Gunther Wernsdorfer; Kanungnit Congpuong; Chaiporn Rojanawatsirivet; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704

7.  Chloroquine resistance of Plasmodium falciparum in Brazil detected by a simple in vitro method.

Authors:  K H Rieckmann; F J López Antuñano
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

8.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

9.  Characterization of a protein correlated with the production of knob-like protrusions on membranes of erythrocytes infected with Plasmodium falciparum.

Authors:  A Kilejian
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

10.  An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine.

Authors:  Oumaporn Tasanor; Harald Noedl; Kesara Na-Bangchang; Kanungnit Congpuong; Jeeraphat Sirichaisinthop; Walther H Wernsdorfer
Journal:  Acta Trop       Date:  2002-07       Impact factor: 3.112

View more
  3 in total

1.  Parameterization of high magnetic field gradient fractionation columns for applications with Plasmodium falciparum infected human erythrocytes.

Authors:  Stephan Karl; Timothy M E Davis; Tim G St Pierre
Journal:  Malar J       Date:  2010-05-03       Impact factor: 2.979

2.  Monitoring of clinical efficacy and in vitro sensitivity of Plasmodium vivax to chloroquine in area along Thai Myanmar border during 2009-2010.

Authors:  Poonuch Muhamad; Ronnatrai Ruengweerayut; Wanna Chacharoenkul; Kanchana Rungsihirunrat; Kesara Na-Bangchang
Journal:  Malar J       Date:  2011-02-16       Impact factor: 2.979

3.  Susceptibility of human Plasmodium knowlesi infections to anti-malarials.

Authors:  Farrah A Fatih; Henry M Staines; Angela Siner; Mohammed Atique Ahmed; Lu Chan Woon; Erica M Pasini; Clemens Hm Kocken; Balbir Singh; Janet Cox-Singh; Sanjeev Krishna
Journal:  Malar J       Date:  2013-11-19       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.